Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 5.1 Opinion of Goldfarb Gross Seligman & Co., Israeli Counsel to the Registrant
- 5.2 Opinion of Covington & Burling LLP, U.S. Counsel to the Registrant
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Somekh Chaikin (Member Firm of KPMG International), Independent Registered Public Accounting Firm
- EX-FILING FEES Filing Fee Table
Associated filings
- 9 Apr 24 EFFECT Notice of effectiveness
- 4 Apr 24 POS AM Prospectus update (post-effective amendment)
- 7 Sep 23 424B3 Prospectus supplement
- 6 Sep 23 EFFECT Notice of effectiveness
- 31 Aug 23 F-1/A Registration statement (foreign) (amended)
- 14 Aug 23 F-1/A Registration statement (foreign) (amended)
-
21 Jul 23 F-1 Registration statement (foreign)
NRSN similar filings
- 10 May 24 Registration statement (foreign)
- 31 Aug 23 Registration statement (foreign) (amended)
- 14 Aug 23 Registration statement (foreign) (amended)
- 21 Jul 23 Registration statement (foreign)
- 6 Dec 21 Registration statement (foreign) (amended)
- 19 Nov 21 Registration statement (foreign) (amended)
- 10 Nov 21 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 20, 2023, with respect to the consolidated financial statements of NeuroSense Therapeutics Ltd., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ Somekh Chaikin
Member Firm of KPMG International
Tel-Aviv, Israel
July 21, 2023